RELiZORB®
K-Number: K232784 · 2023-12-21
Device Summary
Frequently Asked Questions
What is the RELiZORB®?
RELiZORB® is a medical device that received FDA 510(k) clearance on 2023-12-21. The listed applicant is Alcresta Therapeutics, Inc.. The 510(k) number is K232784.
When did RELiZORB® receive FDA 510(k) clearance?
RELiZORB® received FDA 510(k) clearance on 2023-12-21, under 510(k) number K232784.
Who is the listed applicant for RELiZORB®?
The FDA 510(k) record lists Alcresta Therapeutics, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for RELiZORB®?
The FDA product code for RELiZORB® is PLQ.
Other records listing Alcresta Therapeutics, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PLQ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.